HORIZON THERAPEUTICS

HZNP

Delayed - 03/08 04:00:01 pm
86.77USD	-2.12%

05/12/21	Q1 2021 Earnings Release (Projected)
08/11/21	Interim 2021 Earnings Release (Projected)
11/08/21	Q3 2021 Earnings Release (Projected)
03/02/22	FY 2021 Earnings Release (Projected)

03/02/21 \| 01:30pm	Cowen & Co. Health Care Conference
02/24/21 \| 08:00am	FY 2020 Earnings Call
02/24/21 \| 07:00am	FY 2020 Earnings Release
02/01/21 \| 08:00am	Acquisition of Viela Bio, Inc by Horizon Therapeutics Plc Call

03/09/21	CURALEAF HOLDINGS, INC. : FY 2020 Earnings Release
03/09/21	ASTRAZENECA PLC : Carnegie Nordic Healthcare Seminar
03/09/21	ASTRAZENECA PLC : Barclays Global Healthcare Conference
03/09/21	ASTRAZENECA PLC : Daiwa, Investment Conference

03/08/21	ASTRAZENECA PLC : Bank of America Healthcare Bus Tour
03/06/21	MERCK & CO., INC. : Retroviruses and Opportunistic Infections Conference
03/04/21 \| 12:50pm	BIOMARIN PHARMACEUTICAL INC. : Cowen & Co. Health Care Conference
03/04/21 \| 12:50pm	AMGEN INC. : Cowen & Co. Health Care Conference

Previous year

Next Year

Annual results		2016	2017	2018	2019	2020	2021 (e)
Sales M $	Released Forecast Spread	981 1 046 -6,2%	1 056 1 046 0,94%	1 208 1 187 1,8%	1 300 1 286 1,1%	2 200 2 149 2,4%	2 781
Operating income (EBITDA) M $	Released Forecast Spread	471 459 2,6%	390 378 3,2%	451 428 5,6%	483 474 1,8%	999 987 1,2%	1 106
Operating profit (EBIT) M $	Released Forecast Spread	-147 461 -132%	383 372 3,0%	450 429 5,0%	481 470 2,4%	996 946 5,2%	1 062
Pre-Tax Profit (EBT) M $	Released Forecast Spread			-119	-20,2 405 -105%	402	970
Net income M $	Released Forecast Spread	-167 -20,5 -714%	-411 -426 3,7%		573 2,93 19 463%	390 320 22%	128
EPS $	Released Forecast Spread	-1,04 -0,12 -740%	-2,52 -2,56 1,7%		2,90 0,02 14 400%	1,81 1,44 26%	0,54
Announcement Date		02/27/2017	02/28/2018	02/27/2019	02/26/2020	02/24/2021

Previous period

Next period

Quarterly results		2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)
Sales M $	Released Forecast Spread	325 312 4,3%	356 334 6,4%	280 238 18%	321 296 8,2%	335 331 1,5%	364 349 4,1%	356 288 24%	463 334 39%	636 531 20%	745 693 7,6%	422	672	801	893	829
Operating income (EBITDA) M $	Released Forecast Spread	150 118 27%	151 126 20%	88,4 41,6 112%	124 96,6 29%	130 123 5,9%	140 131 6,8%	107 52,3 105%	191 93,3 104%	330 220 50%	371 325 14%	75,3	265	343	416
Operating profit (EBIT) M $	Released Forecast Spread	150 121 23%	151 130 16%	88,1 46,7 89%	124 96,2 29%	129 123 5,4%	139 128 8,7%	106 65,5 62%	190 94,9 100%	330 221 49%	370 322 15%	79,3	246	327	395	320
Pre-Tax Profit (EBT) M $	Released Forecast Spread	24,3	40,7				36,9 115 -68%	-32,6 52,9 -162%	2,95 71,1 -96%			38,2	169	293	470
Net income M $	Released Forecast Spread					18,2 13,6 34%	593 22,6 2 517%	-13,6 -28,8 53%	-80,0 -1,19 -6 610%	293 41,3 609%	191 121 58%	-111	50,2	91,7	97,0
EPS $	Released Forecast Spread					0,09 0,07 29%	2,84 0,12 2 267%	-0,07 -0,14 50%	-0,42 -0,01 -4 100%	1,31 0,18 628%	0,82 0,51 61%
Announcement Date		11/07/2018	02/27/2019	05/08/2019	08/07/2019	11/06/2019	02/26/2020	05/06/2020	08/05/2020	11/02/2020	02/24/2021